Frank Nestle, M.D.

Partner and Chief Executive Officer, 3DC at Deerfield Management · Joined 2024

View Live Interactive Profile →

Biography

Frank Nestle, M.D., is a Partner at Deerfield and Chief Executive Officer of Deerfield Discovery and Development (3DC), and is a member of the Therapeutics team. Deerfield announced his appointment on 5 June 2024. He leads Deerfield's drug discovery and development efforts and applies that expertise across the firm's investment process. Before Deerfield he was Global Head of Research and Chief Scientific Officer at Sanofi, where he oversaw research therapeutic areas and platforms. Earlier he was Professor and Chair of Cutaneous Medicine and Immunotherapy at King's College London and practised medicine at Guy's and St. Thomas Hospital in London and the University Hospital in Zurich. He holds an M.D. from The Julius Maximilian's University of Wuerzburg and is a Fellow of the UK Academy of Medical Sciences. His Deerfield profile states that he has served on the board of several private companies, without naming them.

Education

Previous Experience

Career Timeline

2024
Deerfield announces on 5 June 2024 that he joins as Partner and Chief Executive Officer of Deerfield Discovery and Development (3DC), from Sanofi where he was Global Head of Research and Chief Scientific Officer.

Sources & References

Deerfield - Frank Nestle, M.D. team profile (checked 2026-09-07) ↗Deerfield news - Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development (5 June 2024) ↗